Study published in Nature Communications: Nightingale Health outperforms genetic testing in chronic disease risk detection and makes the promise of preventative health a reality
Nightingale Health Plc Press release 4 December 2024 at 10:00 a.m. (EET) Nightingale Health Plc’s (“Nightingale Health”) peer-reviewed study has been published in Nature Communications, showcasing the accuracy and performance of Nightingale Health’s blood biomarker-based risk prediction models. The world’s largest population study in the field includes data from more than 700,000 participants in three national biobanks from Finland, Estonia and the United Kingdom. The population study findings show that Nightingale Health’